Your browser doesn't support javascript.
loading
Cardiac Hyaluronan Synthesis Is Critically Involved in the Cardiac Macrophage Response and Promotes Healing After Ischemia Reperfusion Injury.
Petz, Anne; Grandoch, Maria; Gorski, Daniel J; Abrams, Marcel; Piroth, Marco; Schneckmann, Rebekka; Homann, Susanne; Müller, Julia; Hartwig, Sonja; Lehr, Stefan; Yamaguchi, Yu; Wight, Thomas N; Gorressen, Simone; Ding, Zhaoping; Kötter, Sebastian; Krüger, Martina; Heinen, Andre; Kelm, Malte; Gödecke, Axel; Flögel, Ulrich; Fischer, Jens W.
Afiliación
  • Petz A; From the Institut für Pharmakologie und Klinische Pharmakologie (A.P., M.G., D.J.G., M.A., M.P., R.S., S.H., J.M., S.G., J.W.F.), University Hospital, Heinrich-Heine-University Düsseldorf, Germany.
  • Grandoch M; CARID, Cardiovascular Research Institute Düsseldorf (A.P., M.G., D.J.G., M.A., M.P., R.S., S.H., J.M., S.G., M. Kelm, A.G., U.F., J.W.F.), University Hospital, Heinrich-Heine-University Düsseldorf, Germany.
  • Gorski DJ; From the Institut für Pharmakologie und Klinische Pharmakologie (A.P., M.G., D.J.G., M.A., M.P., R.S., S.H., J.M., S.G., J.W.F.), University Hospital, Heinrich-Heine-University Düsseldorf, Germany.
  • Abrams M; CARID, Cardiovascular Research Institute Düsseldorf (A.P., M.G., D.J.G., M.A., M.P., R.S., S.H., J.M., S.G., M. Kelm, A.G., U.F., J.W.F.), University Hospital, Heinrich-Heine-University Düsseldorf, Germany.
  • Piroth M; From the Institut für Pharmakologie und Klinische Pharmakologie (A.P., M.G., D.J.G., M.A., M.P., R.S., S.H., J.M., S.G., J.W.F.), University Hospital, Heinrich-Heine-University Düsseldorf, Germany.
  • Schneckmann R; CARID, Cardiovascular Research Institute Düsseldorf (A.P., M.G., D.J.G., M.A., M.P., R.S., S.H., J.M., S.G., M. Kelm, A.G., U.F., J.W.F.), University Hospital, Heinrich-Heine-University Düsseldorf, Germany.
  • Homann S; From the Institut für Pharmakologie und Klinische Pharmakologie (A.P., M.G., D.J.G., M.A., M.P., R.S., S.H., J.M., S.G., J.W.F.), University Hospital, Heinrich-Heine-University Düsseldorf, Germany.
  • Müller J; CARID, Cardiovascular Research Institute Düsseldorf (A.P., M.G., D.J.G., M.A., M.P., R.S., S.H., J.M., S.G., M. Kelm, A.G., U.F., J.W.F.), University Hospital, Heinrich-Heine-University Düsseldorf, Germany.
  • Hartwig S; From the Institut für Pharmakologie und Klinische Pharmakologie (A.P., M.G., D.J.G., M.A., M.P., R.S., S.H., J.M., S.G., J.W.F.), University Hospital, Heinrich-Heine-University Düsseldorf, Germany.
  • Lehr S; CARID, Cardiovascular Research Institute Düsseldorf (A.P., M.G., D.J.G., M.A., M.P., R.S., S.H., J.M., S.G., M. Kelm, A.G., U.F., J.W.F.), University Hospital, Heinrich-Heine-University Düsseldorf, Germany.
  • Yamaguchi Y; From the Institut für Pharmakologie und Klinische Pharmakologie (A.P., M.G., D.J.G., M.A., M.P., R.S., S.H., J.M., S.G., J.W.F.), University Hospital, Heinrich-Heine-University Düsseldorf, Germany.
  • Wight TN; CARID, Cardiovascular Research Institute Düsseldorf (A.P., M.G., D.J.G., M.A., M.P., R.S., S.H., J.M., S.G., M. Kelm, A.G., U.F., J.W.F.), University Hospital, Heinrich-Heine-University Düsseldorf, Germany.
  • Gorressen S; From the Institut für Pharmakologie und Klinische Pharmakologie (A.P., M.G., D.J.G., M.A., M.P., R.S., S.H., J.M., S.G., J.W.F.), University Hospital, Heinrich-Heine-University Düsseldorf, Germany.
  • Ding Z; CARID, Cardiovascular Research Institute Düsseldorf (A.P., M.G., D.J.G., M.A., M.P., R.S., S.H., J.M., S.G., M. Kelm, A.G., U.F., J.W.F.), University Hospital, Heinrich-Heine-University Düsseldorf, Germany.
  • Kötter S; From the Institut für Pharmakologie und Klinische Pharmakologie (A.P., M.G., D.J.G., M.A., M.P., R.S., S.H., J.M., S.G., J.W.F.), University Hospital, Heinrich-Heine-University Düsseldorf, Germany.
  • Krüger M; CARID, Cardiovascular Research Institute Düsseldorf (A.P., M.G., D.J.G., M.A., M.P., R.S., S.H., J.M., S.G., M. Kelm, A.G., U.F., J.W.F.), University Hospital, Heinrich-Heine-University Düsseldorf, Germany.
  • Heinen A; Institute of Clinical Biochemistry and Pathobiochemistry, German Diabetes Center at the Heinrich-Heine-University Duesseldorf, Leibniz Center for Diabetes Research, Germany (S.H., S.L.).
  • Kelm M; German Center for Diabetes Research, München-Neuherberg, Germany (S.H., S.L.).
  • Gödecke A; Institute of Clinical Biochemistry and Pathobiochemistry, German Diabetes Center at the Heinrich-Heine-University Duesseldorf, Leibniz Center for Diabetes Research, Germany (S.H., S.L.).
  • Flögel U; German Center for Diabetes Research, München-Neuherberg, Germany (S.H., S.L.).
  • Fischer JW; Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA (Y.Y.).
Circ Res ; 124(10): 1433-1447, 2019 05 10.
Article en En | MEDLINE | ID: mdl-30916618
ABSTRACT
RATIONALE Immediate changes in the ECM (extracellular matrix) microenvironment occur after myocardial ischemia and reperfusion (I/R) injury.

OBJECTIVE:

Aim of this study was to unravel the role of the early hyaluronan (HA)-rich ECM after I/R. METHODS AND

RESULTS:

Genetic deletion of Has2 and Has1 was used in a murine model of cardiac I/R. Chemical exchange saturation transfer imaging was adapted to image cardiac ECM post-I/R. Of note, the cardiac chemical exchange saturation transfer signal was severely suppressed by Has2 deletion and pharmacological inhibition of HA synthesis 24 hours after I/R. Has2 KO ( Has2 deficient) mice showed impaired hemodynamic function suggesting a protective role for endogenous HA synthesis. In contrast to Has2 deficiency, Has1-deficient mice developed no specific phenotype compared with control post-I/R. Importantly, in Has2 KO mice, cardiac macrophages were diminished after I/R as detected by 19F MRI (magnetic resonance imaging) of perfluorcarbon-labeled immune cells, Mac-2/Galectin-3 immunostaining, and FACS (fluorescence-activated cell sorting) analysis (CD45+CD11b+Ly6G-CD64+F4/80+cells). In contrast to macrophages, cardiac Ly6Chigh and Ly6Clow monocytes were unaffected post-I/R compared with control mice. Mechanistically, inhibition of HA synthesis led to increased macrophage apoptosis in vivo and in vitro. In addition, α-SMA (α-smooth muscle actin)-positive cells were reduced in the infarcted myocardium and in the border zone. In vitro, the myofibroblast response as measured by Acta2 mRNA expression was reduced by inhibition of HA synthesis and of CD44 signaling. Furthermore, Has2 KO fibroblasts were less able to contract collagen gels in vitro. The effects of HA/CD44 on fibroblasts and macrophages post-I/R might also affect intercellular cross talk because cardiac fibroblasts were activated by monocyte/macrophages and, in turn, protected macrophages from apoptosis.

CONCLUSIONS:

Increased HA synthesis contributes to postinfarct healing by supporting macrophage survival and by promoting the myofibroblast response. Additionally, imaging of cardiac HA by chemical exchange saturation transfer post-I/R might have translational value.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Cicatrización de Heridas / Daño por Reperfusión Miocárdica / Matriz Extracelular / Hialuronano Sintasas / Ácido Hialurónico / Macrófagos Límite: Animals Idioma: En Revista: Circ Res Año: 2019 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Cicatrización de Heridas / Daño por Reperfusión Miocárdica / Matriz Extracelular / Hialuronano Sintasas / Ácido Hialurónico / Macrófagos Límite: Animals Idioma: En Revista: Circ Res Año: 2019 Tipo del documento: Article País de afiliación: Alemania